Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy.
Jarosz-Biej M, Smolarczyk R, Cichoń T, Kułach N.
Int J Mol Sci. 2019 Jun 29;20(13):3212. doi: 10.3390/ijms20133212.
Treatment of a first patient with FLASH-radiotherapy.
Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond JF, Moeckli R, Vozenin MC.
Radiother Oncol. 2019 Oct;139:18-22. doi: 10.1016/j.radonc.2019.06.019. Epub 2019 Jul 11.
Is it Time to Change Radiotherapy: The Dawning of Chronoradiotherapy?
Harper E, Talbot CJ.
Clin Oncol (R Coll Radiol). 2019 May;31(5):326-335. doi: 10.1016/j.clon.2019.02.010. Epub 2019 Mar 20.
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities.
Wang Z, Tang Y, Tan Y, Wei Q, Yu W.
Cell Commun Signal. 2019 May 17;17(1):47. doi: 10.1186/s12964-019-0362-2.
FLASH Radiotherapy: Mechanisms of Biological Effects and the Therapeutic Potential in Cancer.
Yan O, Wang S, Wang Q, Wang X.
Biomolecules. 2024 Jun 25;14(7):754. doi: 10.3390/biom14070754.
Progress of clinical study on hypofractionated radiotherapy after breast-conserving surgery.
Wei NN, Li F, Cai P, Yin HM, Zhu CM, Zhang Q, Li DJ.
Ann Palliat Med. 2020 Mar;9(2):463-471. doi: 10.21037/apm.2020.02.18. Epub 2020 Mar 17.
Radiobiology.
Ganz JC.
Prog Brain Res. 2022;268(1):23-48. doi: 10.1016/bs.pbr.2021.10.024. Epub 2021 Dec 14.
Radiotherapy-induced skin reactions: assessment and management.
Bostock S, Bryan J.
Br J Nurs. 2016 Feb 25-Mar 9;25(4):S18, S20-4. doi: 10.12968/bjon.2016.25.4.S18.
Medical physics challenges in clinical MR-guided radiotherapy.
Kurz C, Buizza G, Landry G, Kamp F, Rabe M, Paganelli C, Baroni G, Reiner M, Keall PJ, van den Berg CAT, Riboldi M.
Radiat Oncol. 2020 May 5;15(1):93. doi: 10.1186/s13014-020-01524-4.
Management of radiotherapy-induced skin reactions.
Trueman E.
Int J Palliat Nurs. 2015 Apr;21(4):187-92. doi: 10.12968/ijpn.2015.21.4.187.
